Lingmin Zhang | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by Book of Award

Prof. Lingmin Zhang | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Guangzhou Medical University | China

Prof. Lingmin Zhang is a leading researcher whose work integrates pharmaceutics, biomedical materials, and gene delivery, contributing significantly to advanced therapeutic strategies, particularly in lung cancer and inflammatory diseases. With 3,077 citations , 79 publications, and an h-index of 27, the researcher's scholarly impact is widely recognized. The work focuses on innovative nano-based and biomimetic delivery platforms, including nano-PROTACs, exosomes, microfluidic nanovesicles, and CRISPR/Cas9 carriers, offering transformative possibilities for targeted and precision medicine. Supported by major grants from the National Natural Science Foundation of China (projects 82572415, 82072047, 81700382), the researcher has developed cutting-edge strategies such as reprogramming tumor-associated macrophages, overcoming drug resistance in lung cancer, and reversing epigenetic silencing through nanoparticle-mediated gene delivery. Influential publications in high-impact journals—including Journal of Controlled Release, Drug Resistance Updates, ACS Nano, Angewandte Chemie, Advanced Science, and Molecular Cancer—highlight breakthroughs in nano-therapeutics, PROTAC technologies, artificial exosomes, and nucleic-acid delivery systems. Collectively, these contributions position the researcher at the forefront of translational nanomedicine, with ongoing work offering new directions for precision oncology, regenerative strategies, and next-generation drug delivery platforms.

Profile : Scopus | Orcid

Featured Publication

He, M., Peng, Q., Yang, Q., Guan, X., Liu, Q., Chen, R., Zhou, D., Wang, L., Zhang, Y., Li, S., Su, J., & Zhang, L. (2026). In situ reprogramming of tumor associated macrophages with versatile nano-epigenetic inhibitor for lung cancer therapy. Journal of Controlled Release, 2026, 114497.

Zhang, L., He, L., Lin, Y., Wei, J., Tang, S., Lei, X., Lin, X., Zhou, D., Fu, L., Li, Y., He, J., Liang, L., & Yu, X. (2026). The novel strategy to overcome drug-resistant lung cancer: Dual targeting delivery of PROTAC to inhibit cancer-associated fibroblasts and lung cancer cells. Drug Resistance Updates, 84, 101316.

Chen, S., Chen, E., Su, J., Gong, Y., Tang, S., Qin, A., Shen, A., Tang, S., & Zhang, L. (2025). Magnetically navigated nano-PROTAC ameliorates acute lung injury. Journal of Nanobiotechnology, 23, 622.

Li, X., Qin, Z., Wang, S., Zhang, L., & Jiang, X. (2025). Microfluidics-assembled nanovesicles for nucleic acid delivery. Accounts of Chemical Research, 58, 570–582.

Liang, L., Peng, W., Qin, A., Zhang, J., Chen, R., Zhou, D., Zhang, X., Zhou, N., Yu, X., & Zhang, L. (2024). Intracellularly synthesized artificial exosome treats acute lung injury. ACS Nano, 18(32), 21009–21023.

Guan, X., Xu, X., Tao, Y., Deng, X., He, L., Lin, Z., Chang, J., Huang, J., Zhou, D., Yu, X., Wei, M., & Zhang, L. (2024). Dual targeting and bioresponsive nano-PROTAC induced precise and effective lung cancer therapy. Journal of Nanobiotechnology, 22, 692.

Zhang, L., Lin, Y., Li, S., Guan, X., & Jiang, X. (2023). In situ reprogramming of tumor-associated macrophages with internally and externally engineered exosomes. Angewandte Chemie International Edition, 62(11), e202217089.

Liang, L., Cen, H., Huang, J., Qin, A., Xu, W., Wang, S., Chen, Z., Tan, L., Zhang, Q., Yu, X., Yang, X., & Zhang, L. (2022). The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy. Molecular Cancer, 21(1), 186.

Zhang, H., Peng, R., Chen, S., Shen, A., Zhao, L., Tang, W., Wang, X., Li, Z., Zha, Z., Yi, M., & Zhang, L. (2022). Versatile nano-PROTAC-induced epigenetic reader degradation for efficient lung cancer therapy. Advanced Science, 9(29), 2202039.

Zhang, L., Wang, L., Xie, Y., Wang, P., Deng, S., Qin, A., Zhang, J., Yu, X., Zheng, W., & Jiang, X. (2019). Triple-targeting delivery of CRISPR/Cas9 to reduce the risk of cardiovascular diseases. Angewandte Chemie International Edition, 58(36), 12404–12408.

Akanksha Sanghvi | Health Professions | Best Review Article Award

Published on by Book of Award

Dr. Akanksha Sanghvi | Health Professions | Best Review Article Award

Oprava Aesthetics | India

Dr. Akanksha Sanghvi is a globally trained dermatologist, aesthetic physician, researcher, author, and medical innovator, renowned for her expertise in clinical dermatology, trichology, regenerative medicine, and anti-aging science. As the Founder and Medical Director of Oprava Aesthetics, Mumbai, she has established one of India’s most advanced centers integrating evidence-based dermatology with aesthetic and regenerative therapies. Her research contributions include publications in leading journals such as the Journal of the European Academy of Dermatology and Venereology and the International Journal of Dermatology, along with authorship in Springer’s Handbook of Cancer and Immunology. A certified peer reviewer for Elsevier and Wiley, she holds two patents for dermatological instruments, with two more pending. Dr. Sanghvi’s pioneering work in stem cell and exosome therapy bridges science and clinical innovation, focusing on hair regeneration, skin rejuvenation, and autism care. Through her NGO, ODE INDIA, she leads an AI-powered tele-dermatology initiative to extend specialized care to rural communities. Recognized as the “Best Young Cosmetic Dermatologist of India,” she continues to advance global standards in aesthetic and regenerative dermatology, merging medical excellence with compassion and social responsibility.

Profile : Orcid

Featured Publications

Sanghvi, A. R. (2020). COVID-19: An overview for dermatologists. International Journal of Dermatology.

Shah, A., & Makhecha, M. (2016). Pustular psoriasis of pregnancy with acrodermatitis continua of Hallopeau. Indian Journal of Dermatology.

Shah, A., & Safaya, A. (2013). Spina bifida manifesta: Tethered cord syndrome with pilonidal sinus in a 4-month-old baby. Journal of Neuroradiology.

Shah, A., & Safaya, A. (2012). Granulomatous slack skin disease: A review, in comparison with mycosis fungoides. Journal of the European Academy of Dermatology and Venereology.

Bingbing Wu | Health Professions | Best Researcher Award

Published on by Book of Award

Dr. Bingbing Wu | Health Professions | Best Researcher Award

Zhejiang University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits

Dr. Bingbing Wu began his academic journey with a strong foundation in biological sciences and technology, later advancing to doctoral studies in animal science at Zhejiang University. His early academic training provided him with a deep understanding of cellular biology, developmental processes, and molecular mechanisms, which later became central to his research in regenerative medicine and women’s health. These formative years not only shaped his scientific curiosity but also set the stage for his future contributions to stem cell biology and tissue regeneration.

Professional Endeavors

Following his doctoral studies, Dr. Wu pursued postdoctoral research at Zhejiang University School of Medicine and The First Affiliated Hospital of Zhejiang University, where he investigated the molecular underpinnings of tissue regeneration and gynecological diseases. His professional path led him to roles as a research assistant, full-time researcher, and later junior principal investigator at Zhejiang University’s International School of Medicine. Each role deepened his expertise in applying cutting-edge technologies to complex medical problems and allowed him to cultivate leadership in research.

Contributions and Research Focus

Dr. Wu’s research is centered on stem cell biology, regenerative medicine, and women’s reproductive health. His work investigates key stem cells involved in endometrial development and regeneration, along with the regulatory mechanisms driving their differentiation. He applies single-cell and spatial multi-omics technologies to unravel the pathological basis of diseases such as intrauterine adhesions and preeclampsia. By integrating organoid models, he has advanced understanding of maternal-fetal interface formation and disease mechanisms, providing novel insights into therapeutic approaches for obstetric and gynecological conditions.

Accolades and Recognition

Throughout his career, Dr. Wu has earned prestigious recognition through numerous competitive research grants. He has been a principal investigator on projects funded by the National Natural Science Foundation of China and the Zhejiang Province Key Projects, reflecting the national and regional confidence in his scientific leadership. His publications in respected international journals such as ACS Applied Materials & Interfaces, Stem Cell Reports, Cell Discovery, and NPJ Regenerative Medicine highlight his contributions to the advancement of regenerative medicine and biomedical science.

Impact and Influence

Dr. Wu’s work has had a significant impact on the field of regenerative medicine, particularly in women’s reproductive health. His studies have not only elucidated molecular pathways of tissue development but also provided translational potential for developing bioactive materials and therapeutic interventions. By combining experimental and computational approaches, he has expanded the scope of regenerative research, inspiring peers and contributing to the global understanding of complex gynecological disorders.

Legacy and Future Contributions

As a scientist committed to innovation, Dr. Wu continues to push the boundaries of regenerative biology. His current projects focus on human adult uterine cell atlases, endometrial tissue engineering, and the role of specific stromal and immune cell populations in tissue regeneration. With ongoing leadership in funded projects and collaborations, he is shaping a scientific legacy that bridges fundamental biology with clinical application. His future contributions are expected to bring new hope for women suffering from reproductive health disorders.

Publications

Article: Autologous platelet-rich plasma dual-network hydrogel promotes human endometrial regeneration
Authors: Xiao Chen, Chengcheng Zhu, Lu Wang, Jialing Deng, Zhuomin Wang, Xiaolin Wu, Haimin Tan, Yiyuan Qu, Bingbing Wu, Yu Li, Keren Cheng, Jian Xu
Journal: Acta Biomaterialia
Year: 2025

Article: Natural regeneration-inspired sequential delivery of synergistic growth factors for structural and functional endometrial regeneration
Authors: Cheng Zhang, Chengcheng Zhu, Xiao Chen, Xuzhi Chen, Di Zhang, Huafei Zhao, Junwen Zhang, Yu Zhang, Wanwan Xu, Xiaofeng Zhao, Yingying Hu, Wei Wei, Jian Xu, Yu Li, Bingbing Wu
Journal: Acta Biomaterialia
Year: 2025

Article: Reshaping the chromatin landscape in HUVECs from small-for-gestational-age newborns
Authors: Lingling Yan, Zhimin Zhou, Shengcai Chen, Xin Feng, Junwen Mao, Fang Luo, Jianfang Zhu, Xiuying Chen, Yingying Hu, Yuan Wang, Bingbing Wu, Lizhong Du, Chunlin Wang, Liang Gong, Yanfen Zhu
Journal: JCI Insight
Year: 2025

Article: Size- and Dose-Dependent Body-Wide Organ Transcriptomic Responses to Calcium Phosphate Nanomaterials
Authors: Yu Li, Wei Jiang, Nanfang Nie, Jiaqi Xu, Xiaozhao Wang, Junwen Zhang, Jiahuan Guan, Chengcheng Zhu, Cheng Zhang, Ying Gu, Xiaoyi Chen, Shasha Yao, Zi Yin, Bingbing Wu*, Hongwei Ouyang*, Xiaohui Zou*
Journal: ACS Applied Materials & Interfaces
Year: 2023

Article: A Dual-Crosslinked Hydrogel Based on Gelatin Methacryloyl and Sulfhydrylated Chitosan for Promoting Wound Healing
Authors: Shunxian Ji, Yushuang Zhao, Xinrang Zhai, Lu Wang, Huali Luo, Zhiyong Xu, Wei Dong, Bingbing Wu*, Wei Wei*
Journal: International Journal of Molecular Sciences
Year: 2023

Conclusion

Dr. Bingbing Wu stands as a distinguished researcher whose academic dedication, professional achievements, and scientific contributions have left a lasting mark on regenerative medicine. His focus on stem cells, multi-omics, and endometrial regeneration has advanced both theoretical knowledge and applied therapeutic strategies. With continued research, mentorship, and innovation, he is poised to expand his influence further, leaving a legacy of discovery and practical impact in the field of health professions.

Shahbaz Khan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Book of Award

Dr. Shahbaz Khan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Pharmacy Academy, Institute of Foreign Trade and Management University | India

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits

Dr. Shahbaz Khan’s academic journey reflects a strong commitment to pharmaceutical sciences, beginning with foundational studies in pharmacy and advancing through specialized postgraduate training in pharmacology. His scholarly dedication culminated in a doctoral degree in pharmaceutical sciences, where his research explored the phytochemical and pharmacological activities of Betula alnoides bark extracts. These early academic achievements not only provided him with a robust understanding of pharmacological principles but also shaped his future research interests in neuropharmacology, neuroscience, and inflammation studies.

Professional Endeavors

Dr. Khan’s professional career spans diverse academic and administrative roles in reputed institutions. He has served as a faculty member in both assistant and associate professor capacities, mentoring students at undergraduate, postgraduate, and doctoral levels. Alongside his teaching and research responsibilities, he has contributed significantly to institutional development through administrative positions such as hostel warden. His teaching philosophy combines rigorous academic training with practical exposure, ensuring that his students are well-prepared for the pharmaceutical and healthcare industries.

Contributions and Research Focus

Dr. Khan’s research portfolio is extensive and multidisciplinary, with particular emphasis on neuropharmacology, phytochemistry, and inflammation-related pathologies. His studies delve into the therapeutic potential of medicinal plants, the development of advanced drug delivery systems, and the role of nutraceuticals in managing neurodegenerative and chronic diseases. His work also encompasses nanomedicine, regenerative medicine, and targeted therapies, leading to innovations in formulations and biomedical applications. By integrating modern pharmacological techniques with traditional medicinal knowledge, he has made meaningful contributions to both preclinical research and applied therapeutic strategies.

Accolades and Recognition

Dr. Khan has earned multiple national and international honors that recognize his academic excellence and research contributions. His achievements include prestigious travel grants for participating in global scientific programs organized by international brain research organizations, as well as awards for specialized training in molecular neuropharmacology. These recognitions underscore his role as a scholar of global repute and his ability to represent Indian pharmaceutical research on international platforms.

Impact and Influence

The impact of Dr. Khan’s work extends beyond his own research, influencing students, collaborators, and the broader scientific community. His publications in high-impact journals have contributed to advancing knowledge in pharmacology, medicinal chemistry, and biomedical sciences. His patents and innovations in pharmaceutical formulations highlight his ability to bridge the gap between laboratory research and practical healthcare solutions. Through book authorship and editorial contributions, he has also enriched the academic resources available to scholars worldwide.

Legacy and Future Contributions

Dr. Khan’s legacy lies in his ability to combine teaching, research, and innovation into a cohesive professional identity. His mentorship has guided many students toward successful careers in pharmacy and research. Looking ahead, he aims to expand his research in neurotherapeutics, nanomedicine, and herbal pharmacology, with a focus on developing novel, safe, and effective treatments for neurological and inflammatory disorders. His future contributions are expected to further strengthen the role of pharmaceutical sciences in addressing global health challenges.

Publications

Exploring Betula alnoides Bark: Insilico and Preclinical Insights into its Antioxidant and Lipid-Lowering Effects in Hypercholesterolemia
Authors: Shahbaz Khan, Alka Lohani, Prashant Tiwari, Sunil Kumar Kadiri
Journal: Obesity Medicine
Year: 2025

Innovative nanomedicine for fungal infections: Advancing treatments through nanotechnology and mycological approaches
Authors: Alka Lohani, Ritika Saxena, Shahbaz Khan, Ana Figueiras, Filipa Mascarenhas-Melo
Journal: Journal of Drug Delivery Science and Technology
Year: 2025

Tailored polymeric hydrogels for regenerative medicine and drug delivery: From material design to clinical applications
Authors: Alka Lohani, Ritika Saxena, Joana Galvão Duarte, Shahbaz Khan, Ana Figueiras, Filipa Mascarenhas-Melo
Journal: International Journal of Pharmaceutics
Year: 2025

pH-responsive IPN beads of carboxymethyl konjac glucomannan and sodium carboxymethyl cellulose as a controlled release carrier for ibuprofen
Authors: Alka Lohani, Ritika Saxena, Shahbaz Khan, Filipa Mascarenhas-Melo
Journal: International Journal of Biological Macromolecules
Year: 2024

An Insight Into Neuropathic Pain: A Systemic and Up-To-Date Review
Authors: Himanshu Sharma, Tanzeeb Rani, Shahbaz Khan
Journal: International Journal of Pharmaceutical Sciences and Research
Year: 2023

Conclusion

Through unwavering dedication to research, teaching, and innovation, Dr. Shahbaz Khan has established himself as a respected authority in pharmaceutical sciences. His contributions continue to inspire students, peers, and the scientific community at large, ensuring his place as a pivotal contributor to advancements in healthcare and pharmacology.

 

Abdelaziz Ghanemi | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Abdelaziz Ghanemi | Medicine and Dentistry | Best Researcher Award

Laval University | Canada

Author Profile

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Abdelaziz Ghanemi’s academic foundation reflects both intellectual rigor and global engagement. He graduated as the top student from the pharmacy program at Mentouri University of Constantine in Algeria. His quest for advanced scientific knowledge led him to China Pharmaceutical University, where he earned a Master of Science in Pharmacology, completing more than twice the credit requirement. His research there involved high-throughput screening for dopamine D5 receptor ligands—a project using transgenic cell lines and cutting-edge fluorescence assays. He then pursued a Ph.D. in Molecular Medicine at Laval University in Canada. His doctoral thesis was a comprehensive study of gene regulation in obesity and exercise, particularly focusing on TFF2 and SPARC, and was constructed from an impressive 27 peer-reviewed publications, marking an extraordinary achievement in biomedical research.

🧪 Professional Endeavors

Dr. Ghanemi’s professional journey spans Algeria, China, and Canada, covering a spectrum of scientific, academic, and community roles. His appointments include:

👨‍🔬 Postdoctoral Fellowships at CHU de Québec–Université Laval Research Center and LOEX Regenerative Medicine Lab, where he explored obesity, vascular calcification, and 3D bioprinting for tissue engineering.
👨‍🏫 Visiting Scholar at the University of Victoria (2024), working under Prof. Stephanie Willerth on bioprinting applications in regenerative medicine.
🔬 Research Professional at the CHUQ’s Functional Genomics and SAGE platform, applying gene expression tools to decode metabolic and ageing pathways.
🌍 Interpreter and Science Communicator, fluent in Arabic, English, French, and Chinese, enhancing cross-cultural scientific collaboration.

In addition to these, Dr. Ghanemi has participated in numerous internships, including hospital pharmacy and neurobiology labs, and taught pharmacology in China—demonstrating both practical and pedagogical expertise.

🔬 Contributions and Research Focus

Dr. Ghanemi’s research covers some of the most pressing biomedical themes of our time:

🧠 Obesity and metabolism, focusing on gene-environment interactions and exercise-induced molecular changes
💪 Regenerative medicine, especially the roles of SPARC and TFF2 in ageing, obesity, and tissue repair
🧬 Genomic and transcriptomic analysis using transgenic animal models and advanced sequencing platforms
🩺 Chronic kidney disease and mineral bone disorders, examining vitamin D pathways and Wnt/β-catenin signaling

His scholarly productivity includes over 50 scientific articles, a Google Scholar h-index of 22, and contributions to high-impact journals such as Biomedicines, Metabolites, Biology, Medicines, and Cytokine.

🏅 Accolades and Recognition

Dr. Ghanemi’s excellence has been recognized globally:

🥇 “Best Student Award” during his undergraduate pharmacy studies
🏆 Oral Presentation Award at ICOMES & AOCO 2019 in Seoul for research on SPARC and exercise
🎓 Vanier Canada Graduate Scholarship Nominee, one of Canada’s most prestigious honors
💬 “Student Seminar Award” by CHU de Québec Research Center for outstanding research communication
🏅 “I Stand With Her” Award at the Women in Medicine Summit (Chicago), honoring his advocacy for women's health
🌍 Laval University Representative at the Canadian Student Health Research Forum (2021)

These distinctions underscore both the scientific value and societal impact of his work.

🌐 Impact and Influence

Dr. Ghanemi’s influence extends beyond the laboratory. His work on exercise mimetics, bioenergetics, and gene-environment crosstalk holds implications for public health, geriatrics, and personalized medicine. As an editor for a special issue in Biomedicines (2024–2025), he is shaping academic dialogue on metabolism and tissue engineering. His editorial contributions and published opinions have influenced how we view obesity, exercise biology, and post-COVID metabolic health. His multilingual ability and international collaborations make him a bridge between cultures and scientific communities.

🔮 Legacy and Future Contributions

Dr. Ghanemi's trajectory suggests a lasting legacy in translational medicine. His integration of molecular research, clinical relevance, and public health awareness positions him to advance therapeutic development in obesity, regenerative strategies, and age-related diseases. With current projects involving SPARC’s therapeutic applications, vascular biology, and bioprinted tissues, Dr. Ghanemi is at the vanguard of modern biomedical science. His commitment to publishing, mentoring, and interdisciplinary exploration signals continued contributions to global health and scientific progress.

Publications

📄 A Single Intraperitoneal Secreted Protein Acidic and Rich in Cysteine Injection in Mice Is Towards an Exercise-like Phenotype
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Biology
Year: 2025

📄 Obesity and Bone Mineral Density Protection Paradox in Chronic Kidney Disease: Secreted Protein Acidic and Rich in Cysteine as a Piece of the Puzzle?
Authors: Abdelaziz Ghanemi, Fabrice Mac-Way
Journal: Life
Year: 2023

📄 Secreted Protein Acidic and Rich in Cysteine (SPARC) to Manage Coronavirus Disease-2019 (COVID-19) Pandemic and the Post-COVID-19 Health Crisis
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Medicines
Year: 2023

📄 Secreted Protein Acidic and Rich in Cysteine (SPARC)—Mediated Exercise Effects: Illustrative Molecular Pathways against Various Diseases
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Diseases
Year: 2023

📄 DNA Damage as a Mechanistic Link between Air Pollution and Obesity?
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Medicines
Year: 2022

Guoxin Ni | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Guoxin Ni | Medicine and Dentistry | Best Researcher Award

First Affiliated Hospital of Xiamen University | China

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Prof. Guoxin Ni embarked on his academic journey with a strong foundation in [specific field], earning his [degree] from [university] in [year]. His early years were marked by an insatiable curiosity and dedication to understanding [relevant subject], which laid the groundwork for his future contributions to academia and research.

🌟 Professional Endeavors

Over the years, Prof. Ni has been associated with esteemed institutions such as [institution names], where he has played a pivotal role in [teaching/research]. As a [current position] at [university/institution], he has been instrumental in shaping the academic landscape, mentoring students, and spearheading research initiatives that push the boundaries of [field of expertise].

🔬 Contributions and Research Focus

Prof. Ni’s research is centered on [key research areas], where he has made groundbreaking discoveries in [specific topic]. His work on [notable research or project] has been widely recognized, contributing significantly to the advancement of [industry/academic field]. His innovative approaches and methodologies have paved the way for new understandings and applications in [related domain].

🏆 Accolades and Recognition

A recipient of numerous awards, Prof. Ni’s excellence has been acknowledged through [list of notable awards and honors]. His contributions have been celebrated in [journals/conferences], and he continues to be a sought-after speaker and expert in his field.

🌐 Impact and Influence

Beyond academia, Prof. Ni has influenced the broader [industry/field] community through collaborations with [organizations/industries]. His work has inspired budding researchers and professionals alike, setting new benchmarks for innovation and excellence. His leadership in [specific initiative or research group] has fostered a culture of exploration and intellectual growth.

💪 Legacy and Future Contributions

Looking ahead, Prof. Ni remains committed to advancing research in [field], with ongoing projects aimed at [future research direction]. His vision and dedication continue to drive progress, ensuring a lasting legacy in both academic and professional circles. His impact will undoubtedly shape the future of [industry or field] for generations to come.

 

Publications

📄 Mechanosensitive lncRNA H19 promotes chondrocyte autophagy, but not pyroptosis, by targeting miR-148a in post-traumatic osteoarthritis
Authors: Xuchang Zhou, Hong Cao, Tao Liao, Shengyao Liu, Guoxin Ni
Journal: Non-coding RNA Research
Year: 2025

📄 Antioxidant taurine inhibits chondrocyte ferroptosis through upregulation of OGT/Gpx4 signaling in osteoarthritis induced by anterior cruciate ligament transection
Authors: Xuchang Zhou, Yajing Yang, Xu Qiu, Donghai Lin, Guoxin Ni
Journal: Journal of Advanced Research
Year: 2025

📄 Translation, Cross-Culture Adaptation and Measurement Properties of the Simplified Chinese Version of the Osteoarthritis Knowledge Scale
Authors: Ziru Wang, Ben Darlow, Huili Deng, Guoxin Ni
Journal: Musculoskeletal Care
Year: 2024

📄 Tetrathiomolybdate alleviates osteoporosis by activating the PI3K/AKT signaling axis
Authors: Xuchang Zhou, C.H. Cao, Dongxue Wang, Shengyao Liu, Guoxin Ni
Journal: European Cells and Materials
Year: 2024

📄 Evaluation of Quantitative and Selective Sensory Fiber Dysfunction in Patients with Cirrhosis
Authors: Nannan Zhang, Zhiyong Wang, Jianmin Chen, Guoxin Ni, Jun Ni
Journal: Current Neurovascular Research
Year: 2024

Dong Jiang | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Dong Jiang | Medicine and Dentistry | Best Researcher Award

Peking University Third Hospital | Best Researcher Award

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Prof. Dong Jiang embarked on his academic journey in clinical medicine at Peking University, where he earned his Bachelor's degree in 2004. His passion for sports medicine led him to pursue a Master's degree in the field, which he successfully completed in 2007. Determined to further his expertise, he obtained his Doctorate in Sports Medicine from Peking University in 2009. This solid academic foundation laid the groundwork for his future contributions to orthopedic sports medicine and arthroscopic surgery.

👨‍⚕️ Professional Endeavors

Prof. Jiang's professional career has been deeply intertwined with the Peking University Third Hospital. He started as an Attending Surgeon in the Department of Sports Medicine in 2009, refining his skills in arthroscopic surgery and orthopedic sports medicine. His dedication and expertise earned him the position of Associate Surgeon-in-Chief in 2014, followed by a promotion to Associate Professor in 2015. By 2019, he had ascended to the rank of Professor, Ph.D. supervisor, and Surgeon-in-Chief. Today, as the Deputy Director of the Department of Sports Medicine at Peking University Institute of Sports Medicine, he continues to advance the field through clinical excellence and research innovations.

🔬 Contributions and Research Focus

Prof. Jiang has made significant contributions to the field of orthopedic sports medicine, particularly in knee, foot, and ankle surgeries. His clinical expertise includes arthroscopy, anterior cruciate ligament reconstruction, meniscus repair, lateral ankle ligament reconstruction, and cartilage regeneration techniques. His research focuses on:

  • Tissue regeneration using mesenchymal stem cells from different sources
  • Biomechanics and mechanical memory research on stem cells
  • Tissue-engineered meniscus regeneration in sports medicine
  • Meniscus allograft transplantation and its clinical outcomes
  • Cartilage and subchondral bone regeneration
  • 3D-printed scaffolds for orthopedic and sports medicine applications

His groundbreaking studies have resulted in more than 60 research papers, including over 40 published in SCI-indexed journals. Additionally, he has contributed to one clinical practice guideline and seven textbooks on sports medicine in China, further enriching the medical community’s knowledge in this field.

🏆 Accolades and Recognition

Prof. Jiang’s relentless pursuit of excellence has been recognized through multiple prestigious awards. He has received three national and provincial scientific and technology awards for his contributions to sports medicine. His innovative research has secured 16 major research grants, including four from the Natural Science Foundation of China and the Beijing Natural Science Foundation. Moreover, he holds an impressive portfolio of 23 national patents, demonstrating his commitment to advancing medical technology in sports medicine.

🌍 Impact and Influence

Beyond academia and clinical practice, Prof. Jiang’s work has significantly influenced the field of sports medicine. His research on tissue regeneration, biomechanics, and 3D printing has opened new possibilities for treating sports injuries. His contributions to clinical practice guidelines have helped standardize treatments, ensuring better patient outcomes. As an editor and chapter contributor to numerous textbooks, he has played a crucial role in educating the next generation of orthopedic surgeons and sports medicine specialists.

🔮 Legacy and Future Contributions

Prof. Jiang’s legacy is marked by his dedication to bridging clinical expertise with cutting-edge research. As a leader in sports medicine, he continues to push the boundaries of regenerative therapies and orthopedic innovation. His future endeavors will likely focus on enhancing minimally invasive techniques, optimizing regenerative treatments, and mentoring young researchers. With his unwavering commitment to advancing sports medicine, Prof. Jiang is set to leave an indelible mark on the field, ensuring that his work benefits athletes and patients for generations to come.

 

Publications

📄Medial Cystic Osteochondral Lesions of the Talus Exhibited Lower Sports Levels, Higher Cyst Presence Rate, and Inferior Radiological Outcomes Compared With Lateral Lesions Following Arthroscopic Bone Marrow Stimulation

  • Authors: X. Cheng, J. Li, M. Pei, C. Jiao, D. Jiang

  • Journal: Arthroscopy - Journal of Arthroscopic and Related Surgery

  • Year: 2025

📄Adipose Triglyceride Lipase Suppresses Noncanonical Inflammasome by Hydrolyzing LPS

  • Authors: W. Li, Q. Liu, Y. Qian, S. Wang, P. Xia

  • Journal: Nature Chemical Biology

  • Year: 2024

📄Comparison of Subjective and Biomechanical Outcomes Between Proprioceptive Training and Modified Broström-Gould Surgery for Chronic Ankle Instability: A Randomized Controlled Trial

  • Authors: Z. Hou, S. Ren, Y. Hu, S. Zhang, D. Jiang

  • Journal: Orthopaedic Journal of Sports Medicine

  • Year: 2024

📄The Severity of Preoperative Bone Marrow Oedema Negatively Influences Short-Term Clinical Outcomes Following Arthroscopic Bone Marrow Stimulation for Osteochondral Lesions of the Talus

  • Authors: Y. Li, X. Fan, G. Zhou, Q. Zhao, D. Jiang

  • Journal: Knee Surgery, Sports Traumatology, Arthroscopy

  • Year: 2024

📄A Novel Ultrasound Method of Evaluating Dynamic Extrusion of Lateral Meniscus in Healthy Population: Different Patterns of Dynamic Extrusion Revealed Between Lateral and Medial Meniscus

  • Authors: X. Meng, Z. Li, H. Ding, L. Dai, D. Jiang

  • Journal: Journal of Ultrasound in Medicine

  • Year: 2024

 

Peng Chen | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Prof. Peng Chen | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Qingdao University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Prof. Peng Chen's journey in medical research began with a strong foundation in clinical medicine and biomedical sciences. She earned her Bachelor of Medicine degree from Taishan Medical College (1999-2004), where she gained essential medical knowledge and clinical training. Her pursuit of advanced expertise led her to Capital University of Medical Sciences (2004-2007), where she obtained a Master of Science degree, focusing on medical research methodologies and specialized clinical studies. To further deepen her understanding and expertise, she pursued a Doctor of Medicine (2009-2012) at Qingdao University, refining her specialization in ophthalmology and regenerative medicine.

Professional Endeavors 🔬

After completing her master's degree, Prof. Chen embarked on her professional career at the Shandong Eye Institute (2007-2016), a renowned institution dedicated to ophthalmology research. During her tenure, she made significant contributions to vision sciences and ocular disease research, strengthening her expertise in eye-related disorders. In 2016, she transitioned to Qingdao University, where she currently serves as a leading researcher and faculty member. Her role at the university allows her to conduct cutting-edge research on ophthalmology and liver regeneration, mentor young medical scientists, and contribute to the advancement of medical science.

Contributions and Research Focus 🔍

Prof. Chen's research has significantly impacted liver regeneration, macrophage efferocytosis, and ophthalmology, particularly in understanding cellular mechanisms and disease pathophysiology. Some of her key contributions include:

  • Liver Regeneration and Macrophage Efferocytosis: Her recent studies have explored the NLRP3 inflammasome's role in constraining liver regeneration by impairing macrophage efferocytosis (Sci Adv., 2025). Additionally, she has investigated the role of Aquaporin-5 in facilitating liver regeneration via the ROS/GSDMD pathway (Cell Signal., 2025) and how extracellular vesicles containing GAS6 protect the liver from ischemia-reperfusion injury (Cell Death Discov., 2024).
  • Ophthalmology and Ocular Disease Research: She has studied the retinoic acid synthesis pathway in AQP5-deficient mice and its implications for dry eye disease (Invest Ophthalmol Vis Sci., 2024). Her research has also examined the regulation of axon guidance by Slit2 and Netrin-1 signaling in lacrimal gland development (Invest Ophthalmol Vis Sci., 2023).

Prof. Chen’s research not only deepens scientific knowledge in these areas but also paves the way for novel therapeutic strategies for liver and eye diseases.

Accolades and Recognition 🏆

Prof. Chen’s contributions to medical science have been widely recognized through prestigious research grants and peer-reviewed publications. She has received:

  • National Natural Science Foundation of China (2020-2023): RMB 550,000 for research on AQP5’s protective role in lens transparency through miRNA-mediated autophagy.
  • Shandong Provincial Natural Science Foundation (2018-2021): RMB 150,000 for the identification and functional study of Fuchs corneal endothelial dystrophy gene.

Her research has been featured in top-tier scientific journals, including Science Advances, Cell Signal, Cell Death Discovery, and Investigative Ophthalmology & Visual Science, reinforcing her status as a leading expert in regenerative medicine and ophthalmology.

Impact and Influence 🌍

Prof. Chen’s work bridges fundamental research and clinical applications, making a profound impact in both ophthalmology and liver disease treatment. Her findings on macrophage efferocytosis and aquaporins have opened new avenues for therapeutic interventions in liver regeneration, while her contributions to ocular disease mechanisms have enhanced the understanding of corneal and lacrimal gland pathophysiology.

Through her mentorship, collaborations, and academic contributions, she continues to shape the next generation of medical researchers and clinicians, strengthening Qingdao University’s reputation as a hub for medical research excellence.

Legacy and Future Contributions 🚀

With an established track record in liver regeneration and ophthalmic research, Prof. Peng Chen’s future contributions are expected to drive medical innovations in regenerative medicine and precision healthcare. Her work on cellular signaling pathways, extracellular vesicles, and aquaporins will likely inspire new therapeutic breakthroughs in both systemic and ocular diseases. As she continues to lead cutting-edge research, mentor young scientists, and contribute to transformative discoveries, Prof. Chen’s legacy will be one of scientific excellence, innovation, and meaningful impact on global healthcare.

Publications

  • 📄NLRP3 inflammasome constrains liver regeneration through impairing MerTK-mediated macrophage efferocytosis

    • Journal: Science Advances
    • Year: 2025
    • Authors: Wei S, Guan G, Luan X, Yu C, Miao L, Yuan X, Chen P*, Di G*

  • 📄Aquaporin-5 facilitates liver regeneration following hepatectomy via ROS/GSDMD pathway

    • Journal: Cell Signaling
    • Year: 2025
    • Authors: Li B, Di G, Ge H, Song P, Han W, Sun H, Wang D, Chen P*, Wang Y*

  • 📄Extracellular vesicles containing GAS6 protect the liver from ischemia-reperfusion injury by enhancing macrophage efferocytosis via MerTK-ERK-COX2 signaling

    • Journal: Cell Death Discovery
    • Year: 2024
    • Authors: Miao L, Yu C, Guan G, Luan X, Jin X, Pan M, Yang Y, Yan J, Chen P*, Di G*

  • 📄Reticulated Retinoic Acid Synthesis is Implicated in the Pathogenesis of Dry Eye in Aqp5 Deficiency Mice

    • Journal: Investigative Ophthalmology & Visual Science
    • Year: 2024
    • Authors: Ge H, Di G, Li B, Han W, Song P, Han S, Wang D*, Chen P*

  • 📄Regulation of Axon Guidance by Slit2 and Netrin-1 Signaling in the Lacrimal Gland of Aqp5 Knockout Mice

    • Journal: Investigative Ophthalmology & Visual Science
    • Year: 2023
    • Authors: Bai Y, Di G, Ge H, Li B, Zhang K, Zhang D, Wang D*, Chen P*

 

Lucio Neto | Materials Science | Best Researcher Award

Published on by Book of Award

Dr. Lucio Neto | Materials Science | Best Researcher Award

Federal University of Paraná (UFPR) | Brazil

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits 📚🎓

Dr. Lucio Neto’s academic journey is a testament to his dedication to scientific excellence. He began his higher education at the University of Brasília (UnB), where he earned a degree in Biotechnology. His passion for cellular biology and biomaterials fueled his pursuit of advanced studies. Eager to deepen his expertise, he obtained both a Master’s and PhD in Pharmaceutical Sciences from the Federal University of Paraná (UFPR). His doctoral research focused on biopolymeric filaments, utilizing a carbohydrate-protein base to assess their physical properties and applications in cell cultures. This pioneering work set the stage for his contributions to tissue engineering and regenerative medicine.

Professional Endeavors 🔍🏗️

Currently, Dr. Neto serves as a Postdoctoral Researcher at the Polymer Science and Technology Laboratory of the State University of Campinas (Unicamp). His research delves into tissue regeneration, combining additive manufacturing with bioactive particles to develop innovative biomaterials. His professional career also includes a three-year tenure at the Molecular Pathology of Cancer (PMC) Group, where he specialized in bioprospecting and cytotoxic activity of anacardic acid derivatives in human oral cancer cells. Additionally, his work at the Nanobiotechnology Laboratory (Embrapa Genetic Resources and Biotechnology) led to groundbreaking advancements in magnetic iron oxide nanoparticle synthesis for 3D cellular cultures.  Beyond research, Dr. Neto has enriched the academic community as a professor at Solução Diferencial in Brasília, shaping future scientists through his expertise in biotechnology and bioengineering.

Contributions and Research Focus 🔬🧬

Dr. Neto’s research spans multiple cutting-edge fields, including:

  • Biopolymers & 3D Bioprinting – Developing bioengineered materials for regenerative medicine.
  • Tissue Regeneration – Innovating biomaterials through additive manufacturing and bioactive compounds.
  • Nanobiotechnology – Synthesizing nanoparticles to enhance cellular interactions in tissue culture.
  • Cancer Research – Investigating novel compounds with potential therapeutic applications.

His proficiency with state-of-the-art bioprinting and 3D printing technologies has positioned him at the forefront of modern biomedical engineering.

Accolades and Recognition 🏆🎖️

Dr. Neto’s dedication has been acknowledged through numerous awards and accolades. His excellence in research earned him first-place honors in academic events and awards from the Brazilian Agricultural Research Corporation (EMBRAPA). Additionally, his contributions at UnB and UFPR were recognized with honorable mentions, further cementing his status as an outstanding scientist.

Impact and Influence 🌍✨

Through his extensive collaborations with multidisciplinary researchers, Dr. Neto has contributed to groundbreaking innovations in bioengineering. His work has been published in high-impact scientific journals, influencing research in nanobiotechnology, regenerative medicine, and pharmaceutical sciences. His active participation in scientific conferences, through oral presentations and poster sessions, has expanded the reach of his discoveries, inspiring both peers and aspiring researchers in the field.

Legacy and Future Contributions 🚀🔗

As a researcher, educator, and innovator, Dr. Lucio Neto’s contributions extend far beyond academia. His work in biopolymers and tissue regeneration continues to pave the way for new medical breakthroughs. His future endeavors promise further advancements in regenerative medicine, biofabrication, and nanotechnology, pushing the boundaries of scientific discovery.

 

Publications

  • 📄Advancing Hydrogel-Based 3D Cell Culture Systems: Histological Image Analysis and AI-Driven Filament Characterization
    • Authors: Lucio Assis Araujo Neto, Alessandra Maia Freire, Luciano Paulino Silva
    • Journal: Biomedicines
    • Year: 2025
  • 📄Characterization of Hydrogel Filaments: Investigating Behavior, Mechanical Strength, and Degradation Over Time
    • Authors: Lucio Assis Araujo Neto, Luciano Paulino Silva
    • Journal: Polymer Bulletin
    • Year: 2024
  • 📄Influence of Biopolymer Composition and Crosslinking Agent Concentration on the Micro- and Nanomechanical Properties of Hydrogel-Based Filaments
    • Authors: Lucio Assis Araujo Neto, Luciano Paulino Silva
    • Journal: Journal of the Mechanical Behavior of Biomedical Materials
    • Year: 2023
  • 📄Magnetic Nanoparticles Coated with Carbohydrates for 3D Culture of Bacteria
    • Authors: Lucio Assis Araujo Neto
    • Journal: Materials Science and Engineering: C
    • Year: 2020
  • 📄Evaluation of Behavior, Growth, and Swarming Formation of Escherichia coli and Staphylococcus aureus in Culture Medium Modified with Silver Nanoparticles
    • Authors: Lucio Assis Araujo Neto
    • Journal: Microbial Pathogenesis
    • Year: 2020

 

Zhihan Zhu | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Ms. Zhihan Zhu | Medicine and Dentistry | Best Researcher Award

Department of Burn and Plastic Surgery, The First People’s Hospital of Changzhou | China

Author Profile

Scopus

🎓 Early Academic Pursuits

Ms. Zhihan Zhu pursued her Bachelor’s degree at Nantong University, focusing on Clinical Medicine with a specialization in oncology. Her academic excellence earned her scholarships for three consecutive years, reflecting her dedication and outstanding performance throughout her studies. For her Master’s studies, she specialized in Burn and Plastic Surgery at Nantong University’s Xinglin College. Her education also included robust foundational courses in internal medicine, surgery, obstetrics, pediatrics, pathology, and anatomy.

🏥 Professional Endeavors

Ms. Zhu gained substantial clinical experience through internships and residencies at renowned hospitals, including the Jiangsu Provincial Yangzhou Jiangdu People's Hospital and Shanghai Minhang District Oncology Hospital. She excelled in surgical operations, patient management, and medical communication. Her expertise spans advanced techniques like autologous skin grafting, deep vein catheterization, and burn wound management. She also possesses proficiency in clinical documentation, prescription optimization, and patient interaction.

🧪 Contributions and Research Focus

Ms. Zhu’s research focuses on wound healing, tissue regeneration, and therapeutic advancements. Her notable projects include:

  • Developing biomimetic nanoparticles for targeted drug delivery in burn treatment.
  • Exploring the protective effects of artemisinin derivatives on liver damage post-burn injury.
  • Investigating adipose-derived stem cells in scar regeneration.

Her work has led to multiple scholarly publications as a primary or co-author, contributing significantly to advancements in burn surgery and regenerative medicine.

🏆 Accolades and Recognition

Ms. Zhu’s academic journey is marked by numerous honors, including the Master's Research Scholarship at Nantong University for three consecutive years. Her research contributions have been recognized by peers in the scientific community, reflecting her dedication and impact.

🌍 Impact and Influence

Ms. Zhu’s work in innovative surgical techniques and regenerative therapies is improving patient outcomes in burn care. Her ability to integrate clinical expertise with cutting-edge research demonstrates her influence in shaping future medical practices in her field.

🌟 Legacy and Future Contributions

With her strong foundation in clinical medicine and pioneering research, Ms. Zhu is poised to leave a lasting legacy in burn and plastic surgery. Her commitment to academic excellence and patient care will undoubtedly lead to transformative advancements in medicine.

 

Publications

📝Chitooligosaccharides promote diabetic wound healing by mediating fibroblast proliferation and migration

  • Authors: Li, Z., Zhang, C., Wang, L., Zhou, Y., Zhang, Y.
  • Journal: Scientific Reports
  • Year: 2025,

📝Application of minimally invasive debridement for deep second-degree facial burns in the early postburn phase

  • Authors: Zhang, C., Li, Z., Zhang, Q., Hu, K., Zhang, Y.
  • Journal: BMC Surgery
  • Year: 2025

📝Biomimetic nanoparticles of platelet membranes carrying bFGF and VEGFA genes promote deep burn wound healing

  • Authors: Wang, B., Chen, J., Zhang, C., Zhang, Y., Jiang, Y.
  • Journal: International Immunopharmacology
  • Year: 2023

📝Effect of stem cell treatment on burn wounds: A systemic review and a meta-analysis

  • Authors: Qiao, Y., Zhang, Q., Peng, Y., Li, Z., Zhang, Y.
  • Journal: International Wound Journal
  • Year: 2023

📝Identification of nanoparticle-mediated siRNA-ASPN as a key gene target in the treatment of keloids

  • Authors: Dong, Y., Zhang, C., Zhang, Q., Gu, H., Zhang, Y.
  • Journal: Frontiers in Bioengineering and Biotechnology
  • Year: 2022